Boothbay Fund Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-42,852
| Closed | – | – | 2310 |
|
2022
Q4 | $0 | Buy |
+42,852
| New | – | ﹤0.01% | 2283 |
|
2020
Q3 | – | Sell |
-94,045
| Closed | -$1.09M | – | 1187 |
|
2020
Q2 | $1.09M | Sell |
94,045
-5,526
| -6% | -$63.8K | 0.07% | 297 |
|
2020
Q1 | $1.36M | Buy |
99,571
+35,824
| +56% | +$491K | 0.11% | 193 |
|
2019
Q4 | $376K | Buy |
63,747
+48,788
| +326% | +$288K | 0.03% | 477 |
|
2019
Q3 | $79K | Sell |
14,959
-633
| -4% | -$3.34K | 0.01% | 616 |
|
2019
Q2 | $120K | Buy |
15,592
+326
| +2% | +$2.51K | 0.01% | 556 |
|
2019
Q1 | $304K | Buy |
15,266
+5,025
| +49% | +$100K | 0.03% | 411 |
|
2018
Q4 | $135K | Buy |
+10,241
| New | +$135K | 0.02% | 447 |
|